Bioengineering research and education at UC Berkeley
Berkeley-Stanford Workshop on Stem Cell Biology and EngineeringWednesday January 11, 2017
10:00 AM-5:30 PM
245 Li Ka Shing Center
Stanford speakers: Michael Clarke, Calvin Kuo, Kyle Loh, Michael Longaker, Thomas Rando, Maria Grazia Roncarolo, Vittorio Sebastiano, Irv Weissman, Joseph Wu
UC Berkeley Speakers: Helen Bateup, Andrew Dillin, Amy Herr, Daniela Kaufer, David Schaffer, Robert Tjian, Mark Walters
|Have a great winter break!|
After severe trauma, some patients in shock develop impaired coagulation. This is difficult to diagnose in crisis and makes blood transfusions dangerously challenging to manage. Professor Adam Arkin and collaborators have used dynamic modeling to demonstrate a method for calculating each patient’s transfusion requirements using only laboratory values that can be easily and quickly obtained in the emergency setting. This personalized information could help hospitals save lives at risk from acute traumatic coagulopathy and massive transfusion mortality.
Congratulations 2013 PhD Tim Downing and 2009 BS Tim Wang, both named to the 2017 Forbes 30 Under 30!
Downing, now a professor at UC Irvine, was recognized for his work examining how extracellular signals can influence the final fate of cells. Wang, now a PhD student at MIT, is the cofounder of KSQ Therapeutics, a drug company that uses his work with the gene-editing technology CRISPR to look for new drugs.
Lygos, a synthetic biology company founded by BioE PhD alumni Jeffrey Dietrich and Eric Steen, was featured in a New York Times article on the resurgence of companies using biology to produce cheap, safe and natural materials for fuel, cosmetics and other goods.